Boost your inner glow and optimize your output with these IV drips to prep you pre-summer and post-summer shine.

Candidate VY1706 demonstrates significant reductions of tau at low doses in NHP study; IND and CTA filings anticipated in ...

Discover how machine learning predicts successful discontinuation of renal therapy in critically ill patients with acute ...

Merck's (MRK) new injectable version of Keytruda aims to overcome regulatory hurdles and market challenges, offering a more ...

US pharma giant Merck & Co (NYSE: MRK) today announced positive top-line results from the pivotal Phase III MK-3475A-D77 ...

"This is the last chapter — if I get another 30, what do I want to do? My mother made it to 97," the actor said.

Kelly's acquisition of Children's Therapy Center (CTC) further expands growth opportunities in the high-margin, high-demand therapeutic services ...

A new type of therapy that ‘edits’ a gene in patients with a rare heart condition has been shown to be safe and effective, ...

Merck (MRK) announced positive topline results from the pivotal Phase 3 MK-3475A-D77 trial. The trial is evaluating the noninferiority of ...

The company is looking to score an FDA nod for its investigational therapy that targets a molecule linked to Guillain-Barré ...

Wilms tumor, a common pediatric kidney cancer, is treatable with surgery, chemotherapy, and radiation therapy for optimal ...

The results were so strong in showing the benefit of this therapy for patient survival that we were able to stop the trial ...